According to the data of World Health Organization, the seasonal influenza in 2010 will become acute earlier than in past years. Rimantadine-«Grindeks» 50mg N20 tablets will be first product in the anti-viral product portfolio of the Company.

The active substance of Rimantadine-«Grindeks» is rimantadine hydrochloride and its commonly used chemical name is rimantadine. For the first time, the substance was synthesized in Latvian Institute of Organic Synthesis 40 years ago.

The price of Rimantadine-«Grindeks» 50mg N20 in the chemistry shops of Latvia will be under 5 Lats per pack.

Chairman of the Board of «Grindeks» Jānis Romanovskis: "As it is well known, the demand determines the supply; therefore we must offer medications in response to the society needs. In this case - anti-flu medication is required and we can be proud, that we are able to provide effective, high quality product produced according to EU high standard requirements for the fight against seasonal influenza!"

Baltic presidents have positive outlook for future Latvia registers EU's fifth steepest drop in exports in first nine months

Comments

Add your own opinion

Liina 18.12.2009 16:50

Only a couple of times I have seen Latvian manufactured drugs in EU countries, why? and the second thing I have heard is that
in some other countries the same drugs are cheaper as in Latvia.

Reply

BOOK A HOTEL. SAVE UP TO 50%

Destination:

Check-in:

Check-out:

RIGIBOR 1M () -
RIGBID 1M () -